Total family unit Helicobacter pylori eradication and pediatric re-infection rates

Stephen Farrell1, Irene Milliken, Gary M Doherty

  • 1Department of Child Health, Institute of Clinical Science, Queen's University Belfast, UK. s.farrell@qub.ac.uk

Helicobacter
|July 24, 2004
PubMed

Insights

Eradicating Helicobacter pylori from an entire family did not significantly reduce childhood re-infection rates. Treating only the infected child is as effective as treating the whole family for preventing H. pylori re-infection.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Family Medicine

Background:

  • Helicobacter pylori re-infection is more common in children than adults.
  • The family unit is implicated in primary childhood H. pylori infection.
  • The role of family in pediatric H. pylori re-infection is unclear.

Purpose of the Study:

  • To investigate if the family unit influences pediatric H. pylori re-infection.
  • To determine if eradicating H. pylori from the entire family reduces childhood re-infection risk.

Main Methods:

  • Fifty families with an H. pylori-infected child were recruited.
  • All family members underwent 13C-urea breath tests.
  • Families were randomized to either treat the entire family or only the index child.

Main Results:

  • Long-term follow-up (mean 62.2 months) showed low re-infection rates in both groups.
  • Re-infection occurred in three children in the 'index case treatment' group versus one in the 'family unit treatment' group.
  • Re-infection rates were 2.4% per patient per year (index case treatment) and 0.7% per patient per year (family unit treatment), p = .31.

Conclusions:

  • This is the first study to assess H. pylori eradication in the entire family unit for pediatric re-infection.
  • The study reports the longest follow-up period for pediatric H. pylori re-infection.
  • Family unit H. pylori eradication does not significantly reduce re-infection rates in children.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.